A Phase 3, Randomized, Multi-Center, Open-Label Study to Evaluate the Efficacy Safety and Tolerability of Albumin....... Grant
Overview
subcontracted through
- Duke University Funding Organization
administered by
total award amount
- 176093.38
direct costs
- 140874.30
sponsor award ID
- HGS1008-C1060 US-043
- HGS1008-C1060US-043
local award ID
- 00063131
Affiliation
contributor
- Nelson, David R Principal Investigator
Identity
PeopleSoft Contract Number
- 00063131